Simon Friedensohn

Critic
DISC Type : C

Senior Director, Machine Learning & Data Engineering at Alloy Therapeutics, Inc.

Riehen, Basel, Switzerland

Overview

Simon Friedensohn is the Senior Director of Machine Learning & Data Engineering and Co-head of the Basel office for Alloy Therapeutics. He is a scientist and entrepreneur with deep expertise in computational biology and protein engineering, having earned his PhD from ETH Zürich. He previously co-founded deepCDR Biologics, which was acquired by Alloy.

Outside of his direct research, Simon has an interest in process and creative problem-solving. When faced with a creative block, he finds that switching tasks, getting a good nights rest, or clearing his mind by cleaning his desk or apartment helps him find a new perspective on challenging problems.

His PhD research at ETH Zürich directly led to the founding of his startup, deepCDR Biologics, which was subsequently acquired by his current employer, Alloy Therapeutics.

Personality Overview

Negotiator

Precise

Objective Thinker

They like to take decisions independently and do not seek others' support often.  They prefer to analyze logically and value objective facts over emotions. They are quite likely to negotiate on pricing or other key terms.

Topics They Care About

ML in Drug Discovery
His career is focused on applying machine learning and deep sequencing to accelerate the discovery and development of therapeutic antibodies, from his startup to his current role at Alloy.
Antibody Engineering
His PhD research and numerous publications focus on engineering antibodies using next-generation sequencing and computational biology to improve their specificity and affinity.
Biotech Entrepreneurship
He co-founded the ETH Zurich spin-off deepCDR Biologics, successfully led it through the Venture Kick accelerator program, and ultimately to its acquisition by Alloy Therapeutics.

Media Appearances

Simon has no verified media appearances

Work History

9-2024
Senior Director, Machine Learning & Data Engineering at Alloy Therapeutics, Inc.
1-2022 - 9-2024
Director, Machine Learning & Data Engineering at Alloy Therapeutics, Inc.
9-2019 - 4-2022
Co-Founder at deepCDR Biologics
2015 - 3-2020
PhD Student at ETH Zürich
4-2014 - 12-2014
Research Intern, pRED, Genetics & Genomics at Roche

Education

2015 - 2020
Doctor of Philosophy - PhD from ETH Zürich
Master of Science - MS from ETH Zürich

More Information

Social Presence :

Prographics :

Exp : 11 Location : Riehen, Basel, Switzerland Job Level : Senior Designation : Senior Director, Machine Learning & Data Engineering at Alloy Therapeutics, Inc.
URL has been copied!

Insights For Selling To Simon

During A Call Or A Meeting

DO's

  • Use phrases like ‘expect X% improvement’, ‘data clearly shows’ etc.
  • Keep some extra margin while sharing pricing, they are likely to negotiate later
  • Be ready to answer many clarity-seeking questions and requests for information

DONT's

  • Avoid phrases like ‘trust me’, ‘others just love’ etc.
  • Don’t try to give too many examples of other users, they like to make their own decisions
  • Don't give superficial answers, they are easily rattled by them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Simon is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Simon

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Simon move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Simon take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Simon

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.